Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Capranico

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|December 13, 1996
Amsacrine-promoted DNA cleavage site determinants for the two human DNA topoisomerase II isoforms alpha and betaK L Marsh, E Willmore, S Tinelli, et al.
Molecular Pharmacology|July 1, 1999
Topoisomerase poisoning activity of novel disaccharide anthracyclinesF Guano, P Pourquier, S Tinelli, et al.
Molecular Pharmacology|July 1, 1995
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivativesP De Isabella, M Palumbo, C Sissi, et al.
Molecular Pharmacology|September 1, 1996
Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformationF Animati, F Arcamone, M Bigioni, et al.
Biochimica Et Biophysica Acta|December 27, 1995
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lungG Giaccone, J van Ark-Otte, G Scagliotti, et al.
Biochemical Pharmacology|January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenedionesP de Isabella, M Palumbo, C Sissi, et al.
Biochemical Pharmacology|May 30, 2001
A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogueM Bigioni, C Salvatore, A Bullo, et al.
Biochemical Pharmacology|March 7, 2001
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesF Arcamone, F Animati, M Bigioni, et al.
Leukemia|April 18, 2006
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independentR Tonelli, R Sartini, R Fronza, et al.
Oncology|September 28, 2001
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenograftsR Supino, D Polizzi, R Pavesi, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|December 13, 1996
Amsacrine-promoted DNA cleavage site determinants for the two human DNA topoisomerase II isoforms alpha and betaK L Marsh, E Willmore, S Tinelli, et al.
Molecular Pharmacology|July 1, 1999
Topoisomerase poisoning activity of novel disaccharide anthracyclinesF Guano, P Pourquier, S Tinelli, et al.
Molecular Pharmacology|July 1, 1995
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivativesP De Isabella, M Palumbo, C Sissi, et al.
Molecular Pharmacology|September 1, 1996
Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformationF Animati, F Arcamone, M Bigioni, et al.
Biochimica Et Biophysica Acta|December 27, 1995
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lungG Giaccone, J van Ark-Otte, G Scagliotti, et al.
Biochemical Pharmacology|January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenedionesP de Isabella, M Palumbo, C Sissi, et al.
Biochemical Pharmacology|May 30, 2001
A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogueM Bigioni, C Salvatore, A Bullo, et al.
Biochemical Pharmacology|March 7, 2001
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesF Arcamone, F Animati, M Bigioni, et al.
Leukemia|April 18, 2006
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independentR Tonelli, R Sartini, R Fronza, et al.
Oncology|September 28, 2001
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenograftsR Supino, D Polizzi, R Pavesi, et al.
Pageof 9